87 related articles for article (PubMed ID: 26155827)
1. Time, timing, and the treatment of diffuse large B-cell lymphoma.
Gerds AT; Sekeres MA
Leuk Lymphoma; 2016 Feb; 57(2):247-248. PubMed ID: 26155827
[No Abstract] [Full Text] [Related]
2. Coexistence of chronic myeloid leukemia and diffuse large B-cell lymphoma with antecedent chronic lymphocytic leukemia: a case report and review of the literature.
Abuelgasim KA; Rehan H; Alsubaie M; Al Atwi N; Al Balwi M; Alshieban S; Almughairi A
J Med Case Rep; 2018 Mar; 12(1):64. PubMed ID: 29524963
[TBL] [Abstract][Full Text] [Related]
3. [Diffuse Large B cell Lymphoma - Modern Dia-gnostics and Molecularly Targeted Treatment].
Pytlík R; Trněný M
Klin Onkol; 2015; 28 Suppl 3():3S64-72. PubMed ID: 26489504
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics and treatment outcome in a Taiwanese population of patients with Epstein-Barr virus-positive diffuse large B-cell lymphoma.
Lu CH; Lee KF; Chen CC; Chen YY; Huang CE; Tsai PS; Tsou HY; Chou HJ; Chen MF; Chen PT; Lee KD; Lung J
Jpn J Clin Oncol; 2014 Dec; 44(12):1164-71. PubMed ID: 25320341
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of rituximab plus CHOP regimen and CHOP regimen alone for treatment of newly diagnosed patients with diffuse large B-cell lymphoma].
Wu HJ; Zhang QY; Chen DF; Guan XJ; Zhang BL; Ma J
Ai Zheng; 2005 Dec; 24(12):1498-502. PubMed ID: 16351800
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological features of primary hepatic diffuse large B-cell lymphoma: a report of seven cases and a literature review.
Zheng J; Hou Y; Zhou R; Zhong D
Int J Clin Exp Pathol; 2015; 8(10):12955-60. PubMed ID: 26722490
[TBL] [Abstract][Full Text] [Related]
7. CXCL9 promotes the progression of diffuse large B-cell lymphoma through up-regulating β-catenin.
Ruiduo C; Ying D; Qiwei W
Biomed Pharmacother; 2018 Nov; 107():689-695. PubMed ID: 30130730
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma.
Ye Q; Xu-Monette ZY; Tzankov A; Deng L; Wang X; Manyam GC; Visco C; Montes-Moreno S; Zhang L; Dybkær K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Ponzoni M; Ferreri AJ; Parsons BM; Møller MB; Piris MA; Winter JN; Medeiros LJ; Hu S; Young KH
Oncotarget; 2016 Jan; 7(3):2401-16. PubMed ID: 26573234
[TBL] [Abstract][Full Text] [Related]
9. Primary cutaneous diffuse large B-cell lymphoma, leg type: diagnostic considerations.
Hristov AC
Arch Pathol Lab Med; 2012 Aug; 136(8):876-81. PubMed ID: 22849734
[TBL] [Abstract][Full Text] [Related]
10. Perfusion and flow extraction product as potential discriminators in untreated follicular and diffuse large B cell lymphomas using volume perfusion CT with attempt at histopathologic explanation.
Spira D; Adam P; Linder C; Spira SM; Pintoffl J; Claussen CD; Horger M
AJR Am J Roentgenol; 2012 Jun; 198(6):1239-46. PubMed ID: 22623535
[TBL] [Abstract][Full Text] [Related]
11. Diffuse large B-cell lymphoma and its variants.
Dominis M; Dzebro S; Gasparov S; Pesut A; Kusec R
Croat Med J; 2002 Oct; 43(5):535-40. PubMed ID: 12402391
[TBL] [Abstract][Full Text] [Related]
12. Treatment response and overall outcome of patients with relapsed and refractory peripheral T-cell lymphoma compared to diffuse large B-cell lymphoma.
Puig N; Wang L; Seshadri T; al-Farsi K; Keating A; Crump M; Kuruvilla J
Leuk Lymphoma; 2013 Mar; 54(3):507-13. PubMed ID: 22897731
[TBL] [Abstract][Full Text] [Related]
13. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Coiffier B; Lepage E; Briere J; Herbrecht R; Tilly H; Bouabdallah R; Morel P; Van Den Neste E; Salles G; Gaulard P; Reyes F; Lederlin P; Gisselbrecht C
N Engl J Med; 2002 Jan; 346(4):235-42. PubMed ID: 11807147
[TBL] [Abstract][Full Text] [Related]
14. EBV+ diffuse large B-cell lymphoma arising within atrial myxoma in Chinese immunocompetent patient.
Liu X; Liu P; Li J
Int J Clin Exp Pathol; 2015; 8(2):2159-64. PubMed ID: 25973119
[TBL] [Abstract][Full Text] [Related]
15. Primary central nervous system diffuse large B-cell lymphoma shows an activated B-cell-like phenotype with co-expression of C-MYC, BCL-2, and BCL-6.
Li X; Huang Y; Bi C; Yuan J; He H; Zhang H; Yu Q; Fu K; Li D
Pathol Res Pract; 2017 Jun; 213(6):659-665. PubMed ID: 28552541
[TBL] [Abstract][Full Text] [Related]
16. Diffuse large B-cell lymphoma with oral manifestations.
Bulut E; Bekçioğlu B; Günhan O; Sener I
J Craniofac Surg; 2011 May; 22(3):1144-7. PubMed ID: 21586973
[TBL] [Abstract][Full Text] [Related]
17. Prognostic implication of leucocyte subpopulations in diffuse large B-cell lymphoma.
Han X; Ruan J; Zhang W; Zhou D; Xu D; Pei Q; Ouyang M; Zuo M
Oncotarget; 2017 Jul; 8(29):47790-47800. PubMed ID: 28548962
[TBL] [Abstract][Full Text] [Related]
18. The NOTCH pathway is recurrently mutated in diffuse large B-cell lymphoma associated with hepatitis C virus infection.
Arcaini L; Rossi D; Lucioni M; Nicola M; Bruscaggin A; Fiaccadori V; Riboni R; Ramponi A; Ferretti VV; Cresta S; Casaluci GM; Bonfichi M; Gotti M; Merli M; Maffi A; Arra M; Varettoni M; Rattotti S; Morello L; Guerrera ML; Sciarra R; Gaidano G; Cazzola M; Paulli M
Haematologica; 2015 Feb; 100(2):246-52. PubMed ID: 25381127
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of CD44v6 in diffuse large B-cell lymphoma.
Inagaki H; Banno S; Wakita A; Ueda R; Eimoto T
Mod Pathol; 1999 May; 12(5):546-52. PubMed ID: 10349995
[TBL] [Abstract][Full Text] [Related]
20. Practical Applications in Immunohistochemistry: Evaluation of Diffuse Large B-Cell Lymphoma and Related Large B-Cell Lymphomas.
O'Malley DP; Auerbach A; Weiss LM
Arch Pathol Lab Med; 2015 Sep; 139(9):1094-107. PubMed ID: 25554969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
